An Expanded Access Program to Provide Nintedanib to Patients With Non-IPF ILD Who Have no Alternative Treatment Possibilities
Expanded Access Use of OFEV (Nintedanib) in Non-IPF Interstitial Lung Disease
1 other identifier
expanded_access
N/A
1 country
6
Brief Summary
This Expanded Access Program is intended to facilitate the availability of OFEV to patients suffering from non Idiopathic Pulmonary Fibrosis-Interstitial Lung Disease (non IPF-ILD) with a progressive clinical course despite Standard of Care treatment and for whom no satisfactory authorised alternative therapy exists or who cannot enter a clinical trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2019
CompletedFirst Posted
Study publicly available on registry
February 18, 2019
CompletedDecember 10, 2024
December 1, 2024
February 14, 2019
December 9, 2024
Conditions
Interventions
twice daily
Eligibility Criteria
You may qualify if:
- None
You may not qualify if:
- \- Patients who are eligible for and can participate in an ongoing non Idiopathic Pulmonary Fibrosis-Interstitial Lung Disease (non IPF-ILD) study will be excluded from participation in this Expanded Access Program (EAP).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Banner University Medical Center Tucson
Tucson, Arizona, 85724, United States
The Lung Research Center, LLC
Chesterfield, Missouri, 63017, United States
Glacier View Research Institute
Kalispell, Montana, 59901, United States
University of Rochester Medical Center
Rochester, New York, 14559, United States
Centra Medical Group
Bedford, Virginia, 24523, United States
Inova Fairfax Medical Campus
Falls Church, Virginia, 22042, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- expanded access
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 14, 2019
First Posted
February 18, 2019
Last Updated
December 10, 2024
Record last verified: 2024-12